Madhya Pradesh Cough Syrup Tragedy: Poison Mistaken For Medicine Kills 16 Children

Madhya Pradesh mourns sixteen children killed by adulterated cough syrup, exposing flaws in pharmaceutical oversight. Chhindwara district recorded the first death in early September.

Within weeks, at least six children under five had died. All of them were prescribed Coldrif or Nextro-DS cough syrups by local doctors to treat mild fevers and colds.

The symptoms escalated rapidly, with children experiencing vomiting and reduced urination, leading doctors to diagnose acute kidney infections.

Despite medical intervention, including emergency dialysis, the children could not be saved.

Toxicity in Medicine Raises Alarming Concerns

A meticulous probe discovered diethylene glycol, a highly lethal chemical, present in the kidney samples of the victims.

Laboratory analyses indicated that Coldrif syrup, made by Sresan Pharmaceuticals in Tamil Nadu, contained a shocking 48.6% concentration of this industrial compound.

These harmful chemicals are typically used in adhesives and brake fluids, but are fatal upon consumption.

The contaminated syrup led to acute renal failure in the affected minors, most of whom hailed from impoverished backgrounds.

Families, in a desperate attempt to fund lifesaving treatments, liquidated property and assets, yet the tragedy could not be averted.

Parents of the victims shared harrowing accounts of their children’s sudden decline after taking the syrup, from vomiting and inability to urinate to final, unsuccessful attempts at saving their lives through dialysis.

As the story broke, authorities responded slowly. Initially, senior health officials in Madhya Pradesh denied contamination, but after mounting evidence, the state imposed a ban on Coldrif and began seizing supplies.

The Centre intervened too, urging all states to rationalise cough syrup usage, especially for children, and warning that most coughs resolve without medication.

Since 2022, diethylene glycol-contaminated syrups have claimed over 300 children’s lives worldwide, including in Gambia and Jammu & Kashmir, the WHO reports.

Experts note that cough medications provide limited benefit for children and can be dangerous.

Families who have lost children face compounded grief and poverty, even as governments promise compensation.

The tragedy underscores the urgent need for stronger regulation of medicines and safer healthcare for children.

Also Read: Bitcoin Hits New All-Time High Of $1,25,245; Marks Eighth Straight Gain